Drug profile · INN
brigatinib
ALUNBRIG
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
brigatinib (ALUNBRIG) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN brigatinib
Brand ALUNBRIG
Route ORAL
Formulation TABLET
ATC code L01XE43
Originator Takeda Pharmaceuticals International AG
Frequently asked questions
What is brigatinib?
brigatinib (ALUNBRIG) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for brigatinib?
ALUNBRIG is a marketed brand name for brigatinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of brigatinib?
brigatinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.